NPI: 1043263189 · SAN JOSE, CA 95126 · Non-Pharmacy Dispensing Site · NPI assigned 05/18/2006
Authorized official MOTSIFF, TOM controls 20+ related entities in our dataset. Read more
| Authorized Official | MOTSIFF, TOM (CFO) |
| NPI Enumeration Date | 05/18/2006 |
Other providers sharing the same authorized official: MOTSIFF, TOM
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 37,870 | $1.96M |
| 2019 | 20,649 | $734K |
| 2020 | 26,308 | $883K |
| 2021 | 43,506 | $1.31M |
| 2022 | 16,630 | $660K |
| 2023 | 26,712 | $1.30M |
| 2024 | 54,190 | $2.21M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 1,491 | 1,486 | $1.18M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15,336 | 14,658 | $923K |
| S4993 | Contraceptive pills for birth control | 6,663 | 6,619 | $659K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6,791 | 6,577 | $645K |
| J3490 | Unclassified drugs | 22,818 | 18,776 | $592K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 5,593 | 5,565 | $521K |
| J7304 | Contraceptive supply, hormone containing patch, each | 602 | 597 | $440K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 18,695 | 17,977 | $413K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 6,954 | 6,795 | $401K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1,812 | 1,807 | $364K |
| 11981 | 1,545 | 1,540 | $272K | |
| 87806 | 15,558 | 13,683 | $262K | |
| J7300 | Intrauterine copper contraceptive (paragard) | 356 | 353 | $234K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 984 | 983 | $233K |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | 348 | 345 | $228K |
| 58300 | 2,830 | 1,441 | $228K | |
| S0199 | Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs | 871 | 869 | $217K |
| 99201 | 2,280 | 2,246 | $162K | |
| 90651 | 580 | 578 | $145K | |
| 57454 | 1,976 | 1,002 | $103K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 5,025 | 4,984 | $85K |
| 11976 | 1,527 | 790 | $83K | |
| A4267 | Contraceptive supply, condom, male, each | 11,525 | 11,368 | $73K |
| 99402 | 2,015 | 1,985 | $64K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 12,090 | 11,898 | $55K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 2,279 | 2,213 | $54K |
| 58301 | 2,057 | 1,061 | $51K | |
| 99401 | 2,162 | 2,132 | $41K | |
| 99403 | 774 | 766 | $34K | |
| 81025 | 15,087 | 14,809 | $34K | |
| S5000 | Prescription drug, generic | 3,980 | 3,778 | $29K |
| J7303 | Contraceptive supply, hormone containing vaginal ring, each | 152 | 151 | $29K |
| 59840 | 280 | 145 | $28K | |
| 99000 | 12,968 | 12,682 | $27K | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | 2,109 | 2,109 | $27K |
| S0190 | Mifepristone, oral, 200 mg | 776 | 775 | $21K |
| 83986 | 8,734 | 7,700 | $18K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 12,058 | 11,865 | $18K |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | 6,669 | 6,520 | $17K |
| 11982 | 412 | 207 | $9K | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 861 | 547 | $9K |
| 57460 | 50 | 25 | $6K | |
| Q3014 | Telehealth originating site facility fee | 473 | 469 | $6K |
| 81002 | 2,307 | 2,229 | $3K | |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | 1,038 | 972 | $3K |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 224 | 216 | $2K |
| 85018 | 1,380 | 1,350 | $1K | |
| S0191 | Misoprostol, oral, 200 mcg | 948 | 938 | $1K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 317 | 312 | $1K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 391 | 389 | $1K |
| 99152 | 32 | 28 | $1K | |
| 76830 | Ultrasound, transvaginal | 13 | 13 | $723.28 |
| T1014 | Telehealth transmission, per minute, professional services bill separately | 475 | 471 | $624.19 |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 12 | 12 | $507.88 |
| 86901 | 168 | 167 | $219.45 | |
| Z7610 | 28 | 24 | $189.58 | |
| 99070 | 23 | 13 | $51.40 | |
| 90686 | 56 | 56 | $46.98 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 14 | 14 | $39.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 13 | 13 | $19.00 |
| 3079F | 34 | 31 | $0.00 | |
| 3074F | 138 | 136 | $0.00 | |
| 1220F | 13 | 13 | $0.00 | |
| 3078F | 80 | 78 | $0.00 | |
| 3077F | 15 | 13 | $0.00 |